|
⚲
|
| Keyboard |
| Berg Edward B
✚
|
|
|---|---|
| CIK # | 0001912178 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001912178] | |
| 4 | [0001912178] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| NABI Biopharmaceuticals | |
| Berg Edward B |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
NABI Biopharmaceuticals VXRT
Common Stock
|
2026-03-24 | Tax withheld | 36,418 | $0.69 | 25,128 |
|
NABI Biopharmaceuticals VXRT
Common Stock
|
2026-03-18 | Tax withheld | 8,072 | $0.63 | 5,085 |
|
NABI Biopharmaceuticals VXRT
Stock Option (right to buy) · derivative
|
2026-03-16 | Grant | 225,000 | $0.00 | |
|
NABI Biopharmaceuticals VXRT
Common Stock
|
2026-03-16 | Grant | 115,000 | $0.00 | |
|
NABI Biopharmaceuticals VXRT
Common Stock
|
2026-02-02 | Tax withheld | 9,265 | $0.61 | 5,652 |
|
NABI Biopharmaceuticals VXRT
Common Stock
|
2025-03-24 | Grant | 406,000 | $0.00 | |
|
NABI Biopharmaceuticals VXRT
Stock Option (right to buy) · derivative
|
2025-03-24 | Grant | 50,000 | $0.00 | |
|
NABI Biopharmaceuticals VXRT
Stock Option (right to buy) · derivative
|
2025-03-24 | Grant | 610,000 | $0.00 | |
|
NABI Biopharmaceuticals VXRT
Common Stock
|
2025-03-18 | Tax withheld | 8,050 | $0.57 | 4,588 |
|
NABI Biopharmaceuticals VXRT
Common Stock
|
2025-02-02 | Tax withheld | 9,242 | $0.68 | 6,285 |
|
NABI Biopharmaceuticals VXRT
Stock Option (right to buy) · derivative
|
2024-03-18 | Grant | 410,000 | $0.00 | |
|
NABI Biopharmaceuticals VXRT
Common Stock
|
2024-03-18 | Grant | 90,000 | $0.00 | |
|
NABI Biopharmaceuticals VXRT
Common Stock
|
2024-02-02 | Tax withheld | 9,220 | $1.20 | 11,064 |
|
NABI Biopharmaceuticals VXRT
Common Stock
|
2023-12-08 | Tax withheld | 33,752 | $0.71 | 23,964 |
|
NABI Biopharmaceuticals VXRT
Common Stock
|
2023-03-17 | Grant | 90,000 | $0.00 | |
|
NABI Biopharmaceuticals VXRT
Common Stock
|
2023-03-17 | Grant | 52,606 | $0.00 | |
|
NABI Biopharmaceuticals VXRT
Stock Option (right to buy) · derivative
|
2023-03-17 | Grant | 410,000 | $0.00 | |
|
NABI Biopharmaceuticals VXRT
Stock Option (right to buy) · derivative
|
2023-03-17 | Grant | 205,000 | $0.00 | |
|
NABI Biopharmaceuticals VXRT
Common Stock
|
2023-03-17 | Grant | 45,000 | $0.00 | |
|
NABI Biopharmaceuticals VXRT
Stock Option (right to buy) · derivative
|
2022-02-15 | Grant | 285,000 | $0.00 |